Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy is a research paper published in Preprints.org (2022). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 3T32CA148062-04S1
University of Iowa Surgical Oncology Research Training Program
National Institutes of Health
Grant: 1S10OD026835-01
IVIS Biolumenscence and Fluorescence Live Animal Imaging
National Institutes of Health
Grant: 3U54CA224083-04S1
Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft Models
National Institutes of Health
Grant: 3P50CA174521-05S3
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
Fields of Study
Keywords
Sustainable Development Goals